
Sign up to save your podcasts
Or
A $30 million dollar, phase 3 clinical trial is about to begin at Northwestern, investigating whether exercise can slow Parkinson's disease progression. Daniel Corcos, PhD, a professor of Physical Therapy and Human Movement Sciences is leading the trial and explains what he hopes to accomplish.
4.8
2525 ratings
A $30 million dollar, phase 3 clinical trial is about to begin at Northwestern, investigating whether exercise can slow Parkinson's disease progression. Daniel Corcos, PhD, a professor of Physical Therapy and Human Movement Sciences is leading the trial and explains what he hopes to accomplish.
6,051 Listeners
43,819 Listeners
90,802 Listeners
90 Listeners
32,136 Listeners
22,131 Listeners
476 Listeners
43,219 Listeners
11,937 Listeners
693 Listeners
3,327 Listeners
111,530 Listeners
4 Listeners
0 Listeners
32 Listeners
7,785 Listeners
6,222 Listeners
413 Listeners
363 Listeners